97
Views
21
CrossRef citations to date
0
Altmetric
Review

Functional neuroimaging of primary headache disorders

&
Pages 1159-1171 | Published online: 10 Jan 2014

References

  • Goadsby PJ. Pathophysiology of cluster headache: a trigeminal autonomic cephalgia. Lancet Neurol.1(4), 251–257 (2002).
  • Goadsby PJ, Lipton RB, Ferrari MD. Migraine-current understanding and treatment. N. Engl. J. Med.346(4), 257–270 (2002).
  • Headache Classification Committee of The International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain (2nd Edition). Cephalalgia24, 1–160 (2004).
  • Leao A. Spreading depression of activity in the cerebral cortex. J. Neurophysiol.7, 391–396 (1944).
  • Lauritzen M. Regional cerebral blood flow during cortical spreading depression in rat brain: increased reactive hyperperfusion in low-flow states. Acta. Neurol. Scand.75(1), 1–8 (1987).
  • Mraovitch S, Calando Y, Goadsby PJ, Seylaz J. Subcortical cerebral blood flow and metabolic changes elicited by cortical spreading depression in rat. Cephalalgia12(3), 137–141 (1992).
  • Olesen J, Larsen B, Lauritzen M. Focal hyperemia followed by spreading oligemia and impaired activation of rCBF in classic migraine. Ann. Neurol.9(4), 344–352 (1981).
  • Olesen J, Friberg, L. SPECT studies in migraine without aura. In: Migraine and Other Headaches: The Vascular Mechanisms. Olesen J (Ed.). Raven, London, UK, 237–243 (1991).
  • Friberg L, Olesen J, Lassen NA, Olsen TS, Karle A. Cerebral oxygen extraction, oxygen consumption, and regional cerebral blood flow during the aura phase of migraine. Stroke25(5), 974–979 (1994).
  • Lauritzen M. Pathophysiology of the migraine aura. The spreading depression theory. Brain117(Pt 1), 199–210 (1994).
  • Cutrer FM, Sorensen AG, Weisskoff RM et al. Perfusion-weighted imaging defects during spontaneous migrainous aura. Ann. Neurol.43(1), 25–31 (1998).
  • Lauritzen M, Skyhoj Olsen T, Lassen NA, Paulson OB. Changes in regional cerebral blood flow during the course of classic migraine attacks. Ann. Neurol.13(6), 633–641 (1983).
  • Friberg L, Olsen TS, Roland PE, Lassen NA. Focal ischaemia caused by instability of cerebrovascular tone during attacks of hemiplegic migraine. A regional cerebral blood flow study. Brain110(Pt 4), 917–934 (1987).
  • Cao Y, Welch KM, Aurora S, Vikingstad EM. Functional MRI-BOLD of visually triggered headache in patients with migraine. Arch. Neurol.56(5), 548–554 (1999).
  • Welch KM, Cao Y, Aurora S, Wiggins G, Vikingstad EM. MRI of the occipital cortex, red nucleus, and substantia nigra during visual aura of migraine. Neurology51(5), 1465–1469 (1998).
  • Hadjikhani N, Sanchez Del Rio M, Wu O et al. Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc. Natl Acad. Sci. USA98(8), 4687–4692 (2001).
  • Afridi S, Kaube H, Goadsby PJ. Occipital activation in glyceryl trinitrate induced migraine with visual aura.J. Neurol. Neurosurg. Psychiatry76(8), 1158–1160 (2005).
  • Barbour PJ, Castaldo JE, Shoemaker EI. Hemiplegic migraine during pregnancy: unusual magnetic resonance appearance with SPECT scan correlation. Headache41(3), 310–316 (2001).
  • Lindahl AJ, Allder S, Jefferson D, Moody A, Martel A. Prolonged hemiplegic migraine associated with unilateral hyperperfusion on perfusion weighted magnetic resonance imaging.J. Neurol. Neurosurg. Psychiatry73(2), 202–203 (2002).
  • Gutschalk A, Kollmar R, Mohr A et al. Multimodal functional imaging of prolonged neurological deficits in a patient suffering from familial hemiplegic migraine. Neurosci. Lett.332(2), 115–118 (2002).
  • Woods RP, Iacoboni M, Mazziotta JC. Brief report: bilateral spreading cerebral hypoperfusion during spontaneous migraine headache. N. Engl. J. Med.331, 1689–692 (1994).
  • Olesen J, Lauritzen M, Tfelt-Hansen P, Henriksen L, Larsen B. Spreading cerebral oligemia in classical- and normal cerebral blood flow in common migraine. Headache22(6), 242–248 (1982).
  • Lauritzen M, Olesen J. Regional cerebral blood flow during migraine attacks by Xenon-133 inhalation and emission tomography. Brain107(Pt 2), 447–461 (1984).
  • Olesen J, Friberg L, Olsen TS et al. Timing and topography of cerebral blood flow, aura, and headache during migraine attacks. Ann. Neurol.28(6), 791–798 (1990).
  • Friberg L, Olesen J, Nicolic I et al. Interictal ‘patchy’ regional cerebral blood flow patterns in migraine patients. A single photon emission computerized tomographic study. Eur. J. Neurol.1, 35–43 (1994).
  • Mirza M, Tutus A, Erdogan F et al. Interictal SPECT with Tc-99m HMPAO studies in migraine patients. Acta. Neurol. Belg.98(2), 190–194 (1998).
  • Friberg L, Olesen J, Iversen HK, Sperling B. Migraine pain associated with middle cerebral artery dilatation: reversal by sumatriptan. Lancet338(8758), 13–17 (1991).
  • Goadsby PJ. Neuroimaging in headache. Microsc. Res. Tech.53(3), 179–187 (2001).
  • Limmroth V, May A, Auerbach P, Wosnitza G, Eppe T, Diener HC. Changes in cerebral blood flow velocity after treatment with sumatriptan or placebo and implications for the pathophysiology of migraine. J. Neurol. Sci.138(1–2), 60–65 (1996).
  • Kruuse C, Thomsen LL, Birk S, Olesen J. Migraine can be induced by sildenafil without changes in middle cerebral artery diameter. Brain126(Pt 1), 241–247 (2003).
  • Lance JW, Lambert GA, Goadsby PJ, Duckworth JW. Brainstem influences on the cephalic circulation: experimental data from cat and monkey of relevance to the mechanism of migraine. Headache23(6), 258–265 (1983).
  • Goadsby PJ, Zagami AS, Lambert GA. Neural processing of craniovascular pain: a synthesis of the central structures involved in migraine. Headache31(6), 365–371 (1991).
  • Welch KM, Nagesh V, Aurora SK, Gelman N. Periaqueductal gray matter dysfunction in migraine: cause or the burden of illness? Headache41(7), 629–637 (2001).
  • Weiller C, May A, Limmroth V et al. Brain stem activation in spontaneous human migraine attacks. Nat. Med.1(7), 658–660 (1995).
  • Bahra A, Matharu MS, Buchel C, Frackowiak RS, Goadsby PJ. Brainstem activation specific to migraine headache. Lancet357(9261), 1016–1017 (2001).
  • Goadsby PJ, Fields HL. On the functional anatomy of migraine. Ann. Neurol.43(2), 272 (1998).
  • May A. Headache: lessons learned from functional imaging. Br. Med. Bull.65, 223–234 (2003).
  • Matharu MS, Bartsch T, Ward N, Frackowiak RS, Weiner R, Goadsby PJ. Central neuromodulation in chronic migraine patients with suboccipital stimulators: a PET study. Brain127(Pt 1), 220–230 (2004).
  • Afridi SK, Giffin NJ, Kaube H et al. A positron emission tomographic study in spontaneous migraine. Arch. Neurol.62(8), 1270–1275 (2005).
  • Bingel U, Quante M, Knab R, Bromm B, Weiller C, Buchel C. Single trial fMRI reveals significant contralateral bias in responses to laser pain within thalamus and somatosensory cortices. Neuroimage18(3), 740–748 (2003).
  • Denuelle M, Fabre M, Payoux P, Chollet F, Gerard G. Brainstem and hypothalamic activation in spontaneous migraine attacks: a PET study. Abstract in the 15th Migraine Trust International Symposium. Cephalagia24, 782 (2004).
  • Knight YE, Goadsby PJ. The periaqueductal grey matter modulates trigeminovascular input: a role in migraine? Neuroscience106(4), 793–800 (2001).
  • Ophoff RA, Terwindt GM, Vergouwe MN et al. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell87(3), 543–552 (1996).
  • Knight YE, Bartsch T, Kaube H, Goadsby PJ. P/Q-type calcium-channel blockade in the periaqueductal gray facilitates trigeminal nociception: a functional genetic link for migraine? J. Neurosci.22(5), RC213 (2002).
  • Ciancarelli I, Tozzi-Ciancarelli MG, Di Massimo C, Marini C, Carolei A. Flunarizine effects on oxidative stress in migraine patients. Cephalalgia24(7), 528–532 (2004).
  • Tobita M, Hino M, Ichikawa N, Takase S, Ogawa A. A case of hemiplegic migraine treated with flunarizine. Headache27(9), 487–488 (1987).
  • Silver K, Andermann F. Alternating hemiplegia of childhood: a study of 10 patients and results of flunarizine treatment. Neurology43(1), 36–41 (1993).
  • Yu W, Horowitz SH. Treatment of sporadic hemiplegic migraine with calcium-channel blocker verapamil. Neurology60(1), 120–121 (2003).
  • Goadsby PJ, Gundlach AL. Localization of 3H-dihydroergotamine-binding sites in the cat central nervous system: relevance to migraine. Ann. Neurol.29(1), 91–94 (1991).
  • Goadsby PJ, Knight Y. Inhibition of trigeminal neurones after intravenous administration of naratriptan through an action at 5-hydroxy-tryptamine (5-HT(1B/1D)) receptors. Br. J. Pharmacol.122(5), 918–922 (1997).
  • Raskin NH, Hosobuchi Y, Lamb S. Headache may arise from perturbation of brain. Headache27(8), 416–420 (1987).
  • Veloso F, Kumar K, Toth C. Headache secondary to deep brain implantation. Headache38(7), 507–515 (1998).
  • Haas DC, Kent PF, Friedman DI. Headache caused by a single lesion of multiple sclerosis in the periaqueductal gray area. Headache33(8), 452–455 (1993).
  • Goadsby PJ. Neurovascular headache and a midbrain vascular malformation: evidence for a role of the brainstem in chronic migraine. Cephalalgia22(2), 107–111 (2002).
  • Afridi S, Goadsby PJ. New onset migraine with a brain stem cavernous angioma.J. Neurol. Neurosurg. Psychiatry74(5), 680–682 (2003).
  • May A, Bahra A, Buchel C, Frackowiak RS, Goadsby PJ. Hypothalamic activation in cluster headache attacks. Lancet352(9124), 275–278 (1998).
  • May A, Bahra A, Buchel C, Turner R, Goadsby PJ. Functional magnetic resonance imaging in spontaneous attacks of SUNCT: short-lasting neuralgiform headache with conjunctival injection and tearing. Ann. Neurol.46(5), 791–794 (1999).
  • Derbyshire SW, Jones AK, Devani P et al. Cerebral responses to pain in patients with atypical facial pain measured by positron emission tomography.J. Neurol. Neurosurg. Psychiatry57(10), 1166–1172 (1994).
  • May A, Kaube H, Buchel C et al. Experimental cranial pain elicited by capsaicin: a PET study. Pain74(1), 61–66 (1998).
  • Sprenger T, Boecker H, Tolle TR, Bussone G, May A, Leone M. Specific hypothalamic activation during a spontaneous cluster headache attack. Neurology62(3), 516–517 (2004).
  • Brooks J, Tracey I. From nociception to pain perception: imaging the spinal and supraspinal pathways. J. Anat.207(1), 19–33 (2005).
  • Knight YE, Classey JD, Lasalandra MP et al. Patterns of fos expression in the rostral medulla and caudal pons evoked by noxious craniovascular stimulation and periaqueductal gray stimulation in the cat. Brain Res.1045(1–2), 1–11 (2005).
  • Dunckley P, Wise RG, Fairhurst M et al. A comparison of visceral and somatic pain processing in the human brainstem using functional magnetic resonance imaging. J. Neurosci.25(32), 7333–7341 (2005).
  • Petrovic P, Ingvar M, Stone-Elander S, Petersson KM, Hansson P. A PET activation study of dynamic mechanical allodynia in patients with mononeuropathy. Pain83(3), 459–470 (1999).
  • Zambreanu L, Wise RG, Brooks JC, Iannetti GD, Tracey I. A role for the brainstem in central sensitisation in humans. Evidence from functional magnetic resonance imaging. Pain114(3), 397–407 (2005).
  • Parvizi J, Damasio AR. Neuroanatomical correlates of brainstem coma. Brain126(Pt 7), 1524–1536 (2003).
  • Cao Y, Aurora SK, Nagesh V, Patel SC, Welch KM. Functional MRI-BOLD of brainstem structures during visually triggered migraine. Neurology59(1), 72–78 (2002).
  • Kruit MC, van Buchem MA, Overbosch J, Ferrari MD, Launer LJ. Iron deposits in migraine: red nucleus and putamen involved? A population-based case–control MR imaging study, the Camera-project. Cephalalgia22, 571 (2002).
  • Russell D. Cluster headache: severity and temporal profiles of attacks and patient activity prior to and during attacks. Cephalalgia1(4), 209–216 (1981).
  • Kudrow L. The cyclic relationship of natural illumination to cluster period frequency. Cephalalgia7(Suppl. 6), 76–78 (1987).
  • Cohen AS, Kaube H. Primary headache disorders and circadian biology: a clinical, imaging and therapy perspective. Headache Currents2(4), 1–7 (2005).
  • Di Piero V, Fiacco F, Tombari D, Pantano P. Tonic pain: a SPET study in normal subjects and cluster headache patients. Pain70(2–3), 185–191 (1997).
  • Hsieh JC, Hannerz J, Ingvar M. Right-lateralized central processing for pain of nitroglycerin-induced cluster headache. Pain67(1), 59–68 (1996).
  • Derbyshire SW, Jones AK, Gyulai F, Clark S, Townsend D, Firestone LL. Pain processing during three levels of noxious stimulation produces differential patterns of central activity. Pain73(3), 431–445 (1997).
  • May A, Bahra A, Buchel C, Frackowiak RS, Goadsby PJ. PET and MRA findings in cluster headache and MRA in experimental pain. Neurology55(9), 1328–1335 (2000).
  • Lance JW, Goadsby PJ. Mechanism and Management of Headache. 7th Edition. Elsevier, New York, NY, USA (2005).
  • Leone M, Franzini A, Broggi G, May A, Bussone G. Long-term follow-up of bilateral hypothalamic stimulation for intractable cluster headache. Brain127(Pt 10), 2259–2264 (2004).
  • Schoenen J, Di Clemente L, Vandenheede M et al. Hypothalamic stimulation in chronic cluster headache: a pilot study of efficacy and mode of action. Brain128(4), 940–947 (2005).
  • Ashburner J, Friston KJ. Voxel-based morphometry-the methods. Neuroimage11(6 Pt 1), 805–821 (2000).
  • May A, Ashburner J, Buchel C et al. Correlation between structural and functional changes in brain in an idiopathic headache syndrome. Nat. Med.5(7), 836–838 (1999).
  • Matharu MS, Good CD, May A, Bahra A, Goadsby PJ. No change in the structure of the brain in migraine: a voxel-based morphometric study. Eur. J. Neurol.10(1), 53–57 (2003).
  • Cohen AS, Matharu MS, Kalisch R, Friston K, Goadsby PJ. Functional MRI in SUNCT shows differential hypothalamic activation with increasing pain. Cephalalgia24, 1098–1099 (2004).
  • Sprenger T, Valet M, Platzer S, Pfaffenrath V, Steude U, Tolle TR. SUNCT: bilateral hypothalamic activation during headache attacks and resolving of symptoms after trigeminal decompression. Pain113(3), 422–426 (2005).
  • Sprenger T, Hammes M, Berthele A, Conrad B, Tolle TR. Hypothalamic activation in trigeminal autonomic cephalgia: functional imaging of an atypical case. Cephalalgia24(9), 753–757 (2004).
  • Leone M, Franzini A, D’Andrea G, Broggi G, Casucci G, Bussone G. Deep brain stimulation to relieve drug-resistant SUNCT. Ann. Neurol.57(6), 924–927 (2005).
  • Matharu M, Cohen AS, Frackowiak RSJ, Goadsby PJ. Posterior hypothalamic activation in paroxysmal hemicrania. Ann. Neurol. (2006) (In press).
  • Matharu MS, Cohen AS, McGonigle DJ, Ward N, Frackowiak RS, Goadsby PJ. Posterior hypothalamic and brainstem activation in hemicrania continua. Headache44(8), 747–761 (2004).
  • Ralph MR, Foster RG, Davis FC, Menaker M. Transplanted suprachiasmatic nucleus determines circadian period. Science247(4945), 975–978 (1990).
  • Reppert SM, Weaver DR. Coordination of circadian timing in mammals. Nature418(6901), 935–941 (2002).
  • Utiger RD. Melatonin-the hormone of darkness. N. Engl. J. Med.327(19), 1377–1379 (1992).
  • Brzezinski A. Melatonin in humans. N. Engl. J. Med.336(3), 186–195 (1997).
  • Kudrow L. Plasma testosterone levels in cluster headache preliminary results. Headache16(1), 28–31 (1976).
  • Leone M, Bussone G. A review of hormonal findings in cluster headache. Evidence for hypothalamic involvement. Cephalalgia13(5), 309–317 (1993).
  • Leone M, D’Amico D, Moschiano F, Fraschini F, Bussone G. Melatonin versus placebo in the prophylaxis of cluster headache: a double-blind pilot study with parallel groups. Cephalalgia16(7), 494–496 (1996).
  • Peres MF, Rozen TD. Melatonin in the preventive treatment of chronic cluster headache. Cephalalgia21(10), 993–995 (2001).
  • Couch JR Jr, Ziegler DK. Prednisone therapy for cluster headache. Headache18(4), 219–221 (1978).
  • Antonaci F, Costa A, Candeloro E, Sjaastad O, Nappi G. Single high-dose steroid treatment in episodic cluster headache. Cephalalgia25(4), 290–295 (2005).
  • Sano K, Mayanagi Y, Sekino H, Ogashiwa M, Ishijima B. Results of stimulation and destruction of the posterior hypothalamus in man. J. Neurosurg.33(6), 689–707 (1970).
  • Bejjani BP, Houeto JL, Hariz M et al. Aggressive behavior induced by intraoperative stimulation in the triangle of Sano. Neurology59(9), 1425–1427 (2002).
  • Bahra A, May A, Goadsby PJ. Cluster headache: a prospective clinical study with diagnostic implications. Neurology58(3), 354–361 (2002).
  • Peres MF, Sanchez del Rio M, Seabra ML et al. Hypothalamic involvement in chronic migraine.J. Neurol. Neurosurg. Psychiatry71(6), 747–751 (2001).
  • May A, Goadsby PJ. The trigeminovascular system in humans: pathophysiologic implications for primary headache syndromes of the neural influences on the cerebral circulation. J. Cereb. Blood Flow Metab.19(2), 115–127 (1999).
  • Benjamin L, Levy MJ, Lasalandra MP et al. Hypothalamic activation after stimulation of the superior sagittal sinus in the cat: a Fos study. Neurobiol. Dis.16(3), 500–505 (2004).
  • Malick A, Burstein R. Cells of origin of the trigeminohypothalamic tract in the rat. J. Comp. Neurol.400(1), 125–144 (1998).
  • Bartsch T, Levy MJ, Knight YE, Goadsby PJ. Differential modulation of nociceptive dural input to [hypocretin] orexin A and B receptor activation in the posterior hypothalamic area. Pain109(3), 367–378 (2004).
  • Jones AK, Kulkarni B, Derbyshire SW. Pain mechanisms and their disorders. Br. Med. Bull.65, 83–93 (2003).
  • Matharu M, Cohen AS, Frackowiak RSJ, Goadsby PJ. Posterior hypothalamic activation in paroxysmal hemicrania using PET. Cephalagia25, 859 (2005).
  • Lance JW. Mechanisms and Management of Headache. 6th Edition. Butterworth Heinemann, Oxford, UK (1998).
  • Newman LC, Spears RC, Lay CL. Hemicrania continua: a third case in which attacks alternate sides. Headache44(8), 821–823 (2004).
  • Young WB, Rozen TD. Bilateral cluster headache: case report and a theory of (failed) contralateral suppression. Cephalalgia19(3), 188–190 (1999).
  • Wang W, Timsit-Berthier M, Schoenen J. Intensity dependence of auditory evoked potentials is pronounced in migraine: an indication of cortical potentiation and low serotonergic neurotransmission? Neurology46(5), 1404–1409 (1996).
  • Afra J, Cecchini AP, De Pasqua V, Albert A, Schoenen J. Visual evoked potentials during long periods of pattern-reversal stimulation in migraine. Brain121(Pt 2), 233–241 (1998).
  • Welch KM, Levine SR, D’Andrea G, Schultz LR, Helpern JA. Preliminary observations on brain energy metabolism in migraine studied by in vivo phosphorus 31 NMR spectroscopy. Neurology39(4), 538–541 (1989).
  • Barbiroli B, Montagna P, Cortelli P et al. Abnormal brain and muscle energy metabolism shown by 31P magnetic resonance spectroscopy in patients affected by migraine with aura. Neurology42(6), 1209–1214 (1992).
  • Montagna P, Cortelli P, Monari L et al. 31P-magnetic resonance spectroscopy in migraine without aura. Neurology44(4), 666–669 (1994).
  • Montagna P. Magnetic resonance spectroscopy in migraine. Cephalalgia15(4), 323–327 (1995).
  • Watanabe H, Kuwabara T, Ohkubo M, Tsuji S, Yuasa T. Elevation of cerebral lactate detected by localized 1H-magnetic resonance spectroscopy in migraine during the interictal period. Neurology47(4), 1093–1095 (1996).
  • Schoenen J. Pathogenesis of migraine: the biobehavioral and hypoxia theories reconciled. Acta. Neurol. Belg.94(2), 79–86 (1994).
  • Schoenen J. Cortical electrophysiology in migraine and possible pathogenetic implications. Clin. Neurosci.5(1), 10–17 (1998).
  • Bolay H, Reuter U, Dunn AK, Huang Z, Boas DA, Moskowitz MA. Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat. Med.8(2), 136–142 (2002).
  • Moskowitz MA, Nozaki K, Kraig RP. Neocortical spreading depression provokes the expression of c-fos protein-like immunoreactivity within trigeminal nucleus caudalis via trigeminovascular mechanisms. J. Neurosci.13(3), 1167–1177 (1993).
  • Goadsby PJ. Migraine, aura, and cortical spreading depression: why are we still talking about it? Ann. Neurol.49(1), 4–6 (2001).
  • Sandor PS, Dydak U, Schoenen J et al. MR-spectroscopic imaging during visual stimulation in subgroups of migraine with aura. Cephalalgia25(7), 507–518 (2005).
  • Lodi R, Kemp GJ, Montagna P et al. Quantitative analysis of skeletal muscle bioenergetics and proton efflux in migraine and cluster headache. J. Neurol. Sci.146(1), 73–80 (1997).
  • Montagna P, Lodi R, Cortelli P et al. Phosphorus magnetic resonance spectroscopy in cluster headache. Neurology48(1), 113–118 (1997).
  • Lodi R, Iotti S, Cortelli P et al. Deficient energy metabolism is associated with low free magnesium in the brains of patients with migraine and cluster headache. Brain Res. Bull.54(4), 437–441 (2001).
  • Schoenen J, Lenaerts M, Bastings E. High-dose riboflavin as a prophylactic treatment of migraine: results of an open pilot study. Cephalalgia14(5), 328–329 (1994).
  • van der Kuy PH, Merkus FW, Lohman JJ, ter Berg JW, Hooymans PM. Hydroxocobalamin, a nitric oxide scavenger, in the prophylaxis of migraine: an open, pilot study. Cephalalgia22(7), 513–519 (2002).
  • Peikert A, Wilimzig C, Kohne-Volland R. Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study. Cephalalgia16(4), 257–263 (1996).
  • Sandor PS, Di Clemente L, Coppola G et al. Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial. Neurology64(4), 713–715 (2005).
  • Maizels M, Blumenfeld A, Burchette R. A combination of riboflavin, magnesium, and feverfew for migraine prophylaxis: a randomized trial. Headache44(9), 885–890 (2004).
  • Montagna P. Back to vitamins? Cephalalgia22(7), 489–490 (2002).
  • Kudrow L. Response of cluster headache attacks to oxygen inhalation. Headache21(1), 1–4 (1981).
  • Fogan L. Treatment of cluster headache. A double-blind comparison of oxygen v air inhalation. Arch. Neurol.42(4), 362–363 (1985).
  • Wilson JR, Foresman BH, Gamber RG, Wright T. Hyperbaric oxygen in the treatment of migraine with aura. Headache38(2), 112–115 (1998).
  • Ophoff RA, Terwindt GM, Vergouwe MN, Frants RR, Ferrari MD. Wolff Award 1997. Involvement of a Ca2+ channel gene in familial hemiplegic migraine and migraine with and without aura. Dutch Migraine Genetics Research Group. Headache37(8), 479–485 (1997).
  • Terwindt GM, Ophoff RA, Haan J et al. Variable clinical expression of mutations in the P/Q-type calcium channel gene in familial hemiplegic migraine. Dutch Migraine Genetics Research Group. Neurology50(4), 1105–1110 (1998).
  • Haan J, Kors EE, Vanmolkot KR, van den Maagdenberg AM, Frants RR, Ferrari MD. Migraine genetics: an update. Curr. Pain Headache Rep.9(3), 213–220 (2005).
  • De Fusco M, Marconi R, Silvestri L et al. Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump α2 subunit associated with familial hemiplegic migraine type 2. Nat. Genet.33(2), 192–196 (2003).
  • Dichgans M, Freilinger T, Eckstein G et al. Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. Lancet366(9483), 371–377 (2005).
  • Russell MB. Epidemiology and genetics of cluster headache. Lancet Neurol.3(5), 279–283 (2004).
  • Leone M, Russell MB, Rigamonti A et al. Increased familial risk of cluster headache. Neurology56(9), 1233–1236 (2001).
  • Russell MB, Andersson PG, Iselius L. Cluster headache is an inherited disorder in some families. Headache36(10), 608–612 (1996).
  • Russell MB, Andersson PG, Thomsen LL, Iselius L. Cluster headache is an autosomal dominantly inherited disorder in some families: a complex segregation analysis. J. Med. Genet.32(12), 954–956 (1995).
  • Russell MB, Andersson PG, Thomsen LL. Familial occurrence of cluster headache. J. Neurol. Neurosurg. Psychiatry58(3), 341–343 (1995).
  • Cohen AS, Matharu MS, Goadsby PJ. Familial paroxysmal hemicrania. Cephalalgia24, 1099 (2004).
  • Gantenbein AR, Goadsby P. Familial SUNCT. Cephalalgia25(6), 457–459 (2005).
  • Bartsch T, Knight YE, Goadsby PJ. Activation of 5-HT(1B/1D) receptor in the periaqueductal gray inhibits nociception. Ann. Neurol.56(3), 371–381 (2004).
  • Afridi SK, Matharu MS, Lee L et al. A PET study exploring the laterality of brainstem activation in migraine using glyceryl trinitrate. Brain128(Pt 4), 932–939 (2005).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.